Suchergebnisse - (Subject:"CK")

PubPharm (12)

1

BOLERO -- another remarkable step in treatment of breast cancer

enthalten in: Magyar onkologia | 2014

von Rubovszky, G. | Láng, I.

2

HER2-positive breast cancer : available targeted agents and biomarkers for therapy response

enthalten in: Magyar onkologia | 2013

von Mihály, Z. | Gyõrffy, B.

3

Monoclonal antibody therapy in breast cancer

enthalten in: Magyar onkologia | 2013

von Dank, M. | Tõkés, T.

4

First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer

enthalten in: Magyar onkologia | 2013

von Maráz, A. | Bodrogi, I. | Csejtei, A. | +7

5

Nintedanib (BIBF 1120) in the treatment of solid cancers : an overview of biological and clinical aspects

enthalten in: Magyar onkologia | 2012

von Török, S. | Cserepes T, M. | Rényi-Vámos, F. | +1

6

Possibilities for inhibiting tumor-induced angiogenesis : results with multi-target tyrosine kinase inhibitors

enthalten in: Magyar onkologia | 2012

von Török, S. | Döme, B.

7

Recent advancements in the treatment of renal cell carcinoma--focus on international guidelines

enthalten in: Magyar onkologia | 2010

von Biró, K. | Küronya, Z.

8

Non-pegylated doxorubicin (Myocet®) as the less cardiotoxic alternative of free doxorubicin

enthalten in: Magyar onkologia | 2010

von Nagykálnai, T.

9

Lapatinib treatment-option in trastuzumab-resistant breast cancer

enthalten in: Magyar onkologia | 2009

von Pikó, B.

10

Trastuzumab (Herceptin) in the adjuvant treatment of HER-2-positive early breast cancer

enthalten in: Magyar onkologia | 2006

von Láng, I. | Hitre, E.